CD274 and non-small cell lung carcinoma: The meta-analysis demonstrated the efficacy of combining TCM in oral and injectable forms with PD-1/PD-L1 inhibitors, with or without chemotherapy, in enhancing objective response rate, disease control rate, and quality of life in patients with NSCLC.